Furthermore, to find more accurate biomarkers for identifying ESCC patients, we assessed the diagnostic utility of four genes (TP53, FAT3, MLL3, and AJUBA), mutations in which are the most recurrently detected. Here, AJUBA is linked to esophageal squamous cell carcinoma.